# FDA recall D-0736-2022

> **Aurolife Pharma, LLC** · Class II · drug recall initiated 2022-03-17.

## Product

Glycopyrrolate Tablets, USP, 1 mg, 100-count bottle, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, NDC 13107-014-01.

## Reason for recall

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0736-2022
- **Recalling firm:** Aurolife Pharma, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-17
- **Report date:** 2022-04-06
- **Termination date:** 2024-03-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dayton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0736-2022

## Citation

> AI Analytics. FDA recall D-0736-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0736-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*